Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01420289 · ClinicalTrials.gov registry record · NA
Effect of HPIPC for the Treatment of Ischemic Ulcers in Subjects With PAD
A NA study of PVD and Arterial Ulcers, sponsored by Calvary Hospital, Bronx, NY.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT01420289: Completed NA study of PVD and Arterial Ulcers, sponsored by Calvary Hospital, Bronx, NY.
NCT01420289 is a NA study of PVD and Arterial Ulcers that has completed, run by Calvary Hospital, Bronx, NY. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01420289, a NA study of PVD and Arterial Ulcers, has completed, sponsored by Calvary Hospital, Bronx, NY.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the effects of HPIPC for the treatment of symptoms of PAD
Conditions Studied
Interventions
- DEVICE High pressure intermittent pneumatic compression (HPIPC)
- BEHAVIORAL Excercise
Study Locations (1)
New York
- Center for Curative and Palliative wound Care, Calvary Hospital - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01420289 record still lists
NCT01420289 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with PVD appearing as the primary indexed condition, and to 2 interventions - of which High pressure intermittent pneumatic compression (HPIPC) is the first listed.
NCT01420289 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01420289 about?
NCT01420289 is a clinical study titled "Effect of HPIPC for the Treatment of Ischemic Ulcers in Subjects With PAD". To evaluate the effects of HPIPC for the treatment of symptoms of PAD
What is the current status of trial NCT01420289?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2009-01. Estimated completion is 2011-06.
What conditions does trial NCT01420289 study?
This clinical trial studies the following conditions: PVD, Arterial Ulcers.
What interventions are being tested in trial NCT01420289?
The interventions under investigation include: High pressure intermittent pneumatic compression (HPIPC) (DEVICE), Excercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT01420289?
This trial is sponsored by Calvary Hospital, Bronx, NY, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01420289 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01420289's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia